SCHEMBL4849685

SCHEMBL4849685

[CH2]CCC(=O)OCC(OCC)OCC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.37
LMNA P02545 2/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP3A4 P08684 1/20 0.36
TSHR P16473 1/20 0.36
ATM Q13315 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
KDM4E B2RXH2 1/20 0.35
DUSP3 P51452 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
CYP1A2 P05177 1/20 0.34
PRKCA P17252 3/20 0.33
PRKCE Q02156 1/20 0.33
PRKCQ Q04759 1/20 0.33
PRKCD Q05655 1/20 0.33
MGAM O43451 1/20 0.32
GAA P10253 1/20 0.32
SI P14410 1/20 0.32
MGAM2 Q2M2H8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4854694 0.91 MAPT (0.34) MAPTLMNAALDH1A1CYP3A4TSHR
SCHEMBL297785 0.88 MAPT (0.41) MAPTLMNAALDH1A1CYP3A4TSHR
SCHEMBL10923832 0.84 MAPT (0.47) MAPTLMNAALDH1A1CYP3A4TSHR
SCHEMBL1842052 0.84 ALDH1A1 (0.44) MAPTLMNAALDH1A1CYP3A4TSHR
SCHEMBL522535 0.84 MAPT (0.52) MAPTLMNAALDH1A1CYP3A4TSHR
SCHEMBL4848161 0.84 MGAM (0.34) MAPTLMNAALDH1A1CYP3A4TSHR
SCHEMBL10917122 0.82 MAPT (0.55) MAPTLMNAALDH1A1CYP3A4TSHR
SCHEMBL28854607 0.82 MAPT (0.55) MAPTLMNAALDH1A1CYP3A4TSHR
SCHEMBL522729 0.82 MAPT (0.55) MAPTLMNAALDH1A1CYP3A4TSHR
SCHEMBL8918315 0.82 MAPT (0.38) MAPTLMNAALDH1A1CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7329694-B2 Ocular lens JOHNSON & JOHNSON VISION CARE, INC. (US) 2008-02-12 US disclosed
EP-1445641-B1 OCULAR LENS JOHNSON & JOHNSON VISION CARE (US) 2007-10-03 EP disclosed
US-20040201820-A1 Ocular lens JOHNSON & JOHNSON VISION CARE, INC. 2004-10-14 US disclosed
US-20040198938-A1 Monomers, polymers and ophthalmic lenses JOHNSON & JOHNSON VISION CARE, INC. 2004-10-07 US disclosed
EP-1445641-A1 OCULAR LENS Johnson & Johnson Vision Care, Inc. (US) 2004-08-11 EP disclosed
EP-1424339-A1 MONOMERS, POLYMERS AND OPHTHALMIC LENSES Johson & Johnson Vision Care Inc. (US) 2004-06-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040198938-A1 Monomers, polymers and ophthalmic lenses LOXL1, CRYAA, UACA MAPT 4050/4885LMNA 367/4885ALDH1A1 1939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.